2
|
Andreasen L, Ahlberg G, Ægisdottir HM, Sveinbjörnsson G, Lundegaard PR, Hartmann JP, Paludan-Müller C, Hadji-Turdeghal K, Ghouse J, Pehrson S, Jensen HK, Riahi S, Hansen J, Sandgaard N, Sørensen E, Banasik K, Sækmose SG, Bruun MT, Hjalgrim H, Erikstrup C, Pedersen OB, Wittig M, Haunsø S, Ostrowski SR, Franke A, Brunak S, Kanters JK, Ellervik C, Bundgaard H, Ullum H, Gudbjartsson DF, Thorsteinsdottir U, Holm H, Arnar DO, Stefansson K, Svendsen JH, Olesen MS. Genetic Variants Close to TTN, NKX2-5, and MYH6 Associate With AVNRT. Circ Res 2022; 131:862-865. [PMID: 36205134 DOI: 10.1161/circresaha.122.321556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- Laura Andreasen
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.)
| | - Gustav Ahlberg
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.)
| | - Hildur M Ægisdottir
- deCODE genetics/Amgen Inc., Reykjavik, Iceland (H.M.A., G.S., D.F.G., U.T., H.H., K.S.)
| | - Gardar Sveinbjörnsson
- deCODE genetics/Amgen Inc., Reykjavik, Iceland (H.M.A., G.S., D.F.G., U.T., H.H., K.S.)
| | - Pia R Lundegaard
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.)
| | - Jacob P Hartmann
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.)
| | - Christian Paludan-Müller
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.).,Department of Clinical Medicine, University of Copenhagen, Denmark (C.P.-M., S.H., S.R.O., C.E., H.B., J.H.S.)
| | - Katra Hadji-Turdeghal
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.)
| | - Jonas Ghouse
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.)
| | - Steen Pehrson
- Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Denmark (S.P.)
| | - Henrik K Jensen
- Department of Cardiology, Aarhus University Hospital, Denmark (H.K.J.).,Department of Clinical Medicine, Health, Aarhus University, Denmark (H.K.J.)
| | - Sam Riahi
- Department of Cardiology, Aalborg University Hospital, Denmark (S.R.)
| | - Jim Hansen
- Department of Cardiology, Copenhagen University Hospital - Herlev-Gentofte, Copenhagen, Denmark (J.H.)
| | - Niels Sandgaard
- Department of Cardiology, Odense University Hospital, Denmark (N.S.)
| | - Erik Sørensen
- Department of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (E.S., S.R.O., S.B.)
| | - Karina Banasik
- Translational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark (K.B.)
| | - Susanne G Sækmose
- Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark (S.G.S., O.B.P.)
| | - Mie T Bruun
- Department of Clinical Immunology, Odense University Hospital, Denmark (M.T.B.)
| | - Henrik Hjalgrim
- Department of Epidemiological Research, Statens Serum Institut, Copenhagen, Denmark (H.H.)
| | - Christian Erikstrup
- Department of Clinical Immunology, Aarhus University Hospital, Denmark (C.E.).,Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA (C.E.).,Department of Data Support, Region Zealand, Sorø, Denmark (C.E.)
| | - Ole B Pedersen
- Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark (S.G.S., O.B.P.)
| | - Michael Wittig
- Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Germany (M.W., A.F.)
| | - Stig Haunsø
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Clinical Medicine, University of Copenhagen, Denmark (C.P.-M., S.H., S.R.O., C.E., H.B., J.H.S.)
| | - Sisse R Ostrowski
- Department of Clinical Medicine, University of Copenhagen, Denmark (C.P.-M., S.H., S.R.O., C.E., H.B., J.H.S.).,Department of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (E.S., S.R.O., S.B.)
| | | | - Andre Franke
- Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Germany (M.W., A.F.)
| | - Søren Brunak
- Department of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (E.S., S.R.O., S.B.)
| | - Jørgen K Kanters
- Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.)
| | - Christina Ellervik
- Department of Clinical Medicine, University of Copenhagen, Denmark (C.P.-M., S.H., S.R.O., C.E., H.B., J.H.S.)
| | - Henning Bundgaard
- Department of Clinical Medicine, University of Copenhagen, Denmark (C.P.-M., S.H., S.R.O., C.E., H.B., J.H.S.).,Unit of Inherited Cardiac Diseases, Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Denmark (H.B.)
| | - Henrik Ullum
- Statens Serum Institut, Copenhagen, Denmark (H.U.)
| | - Daniel F Gudbjartsson
- deCODE genetics/Amgen Inc., Reykjavik, Iceland (H.M.A., G.S., D.F.G., U.T., H.H., K.S.)
| | | | - Hilma Holm
- deCODE genetics/Amgen Inc., Reykjavik, Iceland (H.M.A., G.S., D.F.G., U.T., H.H., K.S.)
| | - David O Arnar
- Department of Medicine, Landspitali University Hospital, Reykjavik, Iceland (D.O.A.)
| | - Kari Stefansson
- deCODE genetics/Amgen Inc., Reykjavik, Iceland (H.M.A., G.S., D.F.G., U.T., H.H., K.S.)
| | - Jesper H Svendsen
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Clinical Medicine, University of Copenhagen, Denmark (C.P.-M., S.H., S.R.O., C.E., H.B., J.H.S.)
| | - Morten S Olesen
- Laboratory for Molecular Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen Denmark Molecular Cardiology, Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark (L.A., G.A., P.R.L., J.P.H., C.P.-M., K.H.-T., J.G., S.H., J.H.S., M.S.O.).,Department of Biomedical Sciences, University of Copenhagen, Denmark (L.A., G.A., P.R.L., C.P.-M., J.G., J.K.K., M.S.O.)
| |
Collapse
|
3
|
Nymand SB, Hartmann JP, Ryrsø CK, Rossen NS, Christensen RH, Iepsen UW, Berg RMG. Exercise adaptations in COPD: the pulmonary perspective. Am J Physiol Lung Cell Mol Physiol 2022; 323:L659-L666. [PMID: 36165500 DOI: 10.1152/ajplung.00549.2020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
In chronic obstructive pulmonary disease (COPD), the progressive loss of lung tissue is widely considered non-reversible. Thus, various treatment and rehabilitation schemes, including exercise-based pulmonary rehabilitation (PR) are thought to slow down but not reverse or halt the disease. Nonetheless, the adult lung conceals the intrinsic capacity for de novo lung tissue formation in the form of abundant progenitor/stem cell populations. In COPD, these maintain their differentiation potential but appear to be halted by a state of cellular senescence in the mesenchyme, which normally functions to support and coordinate their function. We propose that notably high-intensity interval training may improve the pulmonary gas exchange during exercise in patients with COPD by interrupting mesenchymal senescence, thus reestablishing adaptive angiogenesis. By means of this, the downward spiral of dyspnea, poor quality of life, physical inactivity, and early death often observed in COPD may be halted. If this is the case, the perception of the regenerative capacity of the lungs will be fundamentally changed, which will warrant future clinical trials on various exercise schemes and other treatments targeting the formation of new lung tissue in COPD.
Collapse
Affiliation(s)
- Stine B Nymand
- Centre for Physical Activity Research, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark.,Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Jacob P Hartmann
- Centre for Physical Activity Research, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark.,Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.,Department of Clinical Physiology and Nuclear Medicine, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark
| | - Camilla K Ryrsø
- Centre for Physical Activity Research, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark
| | - Ninna Struck Rossen
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Regitse Højgaard Christensen
- Centre for Physical Activity Research, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark.,Department of Cardiology, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark
| | - Ulrik Winning Iepsen
- Centre for Physical Activity Research, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark.,Department of Anesthesiology and Intensive Care, University Hospital Copenhagen - Bispebjerg Hospital, Denmark
| | - Ronan M G Berg
- Centre for Physical Activity Research, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark.,Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.,Department of Clinical Physiology and Nuclear Medicine, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark
| |
Collapse
|